Abstract: The invention relates to a method for distributed network monitoring. The network comprises a central processing device and a multitude of N measuring devices. Each measuring devices has received from the central device a granularity value. A granularity value is a measure which defines when a report is transmitted to the central processing device and consequently a measure of detected but not reported data. The granularity values Ginit 1 . . . Ginit N initially assigned to the measuring devices form a monotonic series. The central processing device detects when the largest granularity value has to be changed to ensure that a global value derived from the reports will not exceed a threshold value more than a maximal error.

Abstract: The invention relates to a method for distributed network monitoring. The network comprises a central processing device and a multitude of N measuring devices. Each measuring devices has received from the central device a granularity value. A granularity value is a measure which defines when a report is transmitted to the central processing device and consequently a measure of detected but not reported data. The granularity values Ginit 1 . . . Ginit N initially assigned to the measuring devices form a monotonic series. The central processing device detects when the largest granularity value has to be changed to ensure that a global value derived from the reports will not exceed a threshold value more than a maximal error.

Abstract: A photoadjuvant immunotherapeutical method includes the steps of providing a phototherapeutical apparatus, comprising a light source, an optical guidance system, and a patient interface; determining a minimal erythema dose; performing phototherapy by irradiating a target surface with the phototherapeutical apparatus; and performing immunotherapy by exposing the irradiated target surface to an antigen. The method can be applied to treat allergic diseases, including allergic rhinitis, rhinoconjunctivitis, asthma, and atopic dermatitis, as well as to treat autoimmune diseases. UVA, UVB and visible light can be used, emitted from a quartz bulb with a small discharge volume. The phototherapy increases the tolerance of a patient's body toward an antigen. During immunotherapy the irradiated target surface can be exposed to a naturally present antigen or to an administered antigen.